Evicenter
MarkdownMedical informationP&T meetings
Inaxaplin (VX-147)

APOL1-mediated kidney disease

Launch
Not announced
Last updated
162 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionEpidemiology

Prevalence of APOL1-mediated kidney disease

9 evidence topics · 17 sources

United States: high-risk genotype frequency among Black Americans
West Africa and sub-Saharan Africa: high-risk genotype frequency
Company estimates: Vertex Pharmaceuticals statements of the affected population in the United States and Europe, 2024 to 2026